Adeypharma Ltd in London, EC1V 2NX

Description

Data updated on: 01-11-2023

Adeypharma came into being in 2005 as a company enlisted under no 05368334, located at EC1V 2NX London at 128 City Road. The firm has been in business for nineteen years and its current status is active. The enterprise's principal business activity number is 74909, that means Other professional, scientific and technical activities not elsewhere classified. The company's latest financial reports cover the period up to Tuesday 28th February 2023 and the latest annual confirmation statement was released on Wednesday 12th April 2023.

Right now, the limited company is governed by a single managing director: Yewande A., who was appointed in February 2005. In order to support the directors in their duties, the abovementioned limited company has been utilizing the expertise of Adebanke A. as a secretary for the last 19 years.

Yewande A. is the individual with significant control over this firm, has substantial control or influence over the company, owns over 3/4 of company shares and has 3/4 to full of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-02-28	2012-02-28	2013-02-28	2014-02-28	2015-02-28	2016-02-28	2017-02-28	2018-02-28	2019-02-28	2020-02-28	2021-02-28	2022-02-28	2023-02-28
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	7 485	3 203	2 136	2 581	5 513	3 598	3 380

Balance Sheet
Current Assets	10 098	4 766	4 003	4 240	2 556	4 998	3 630	1 630	55 562	102 063	113 065	36 331	68 768
Net Assets Liabilities							3 380	1 630	43 453	99 760	102 368	24 679	61 725
Cash Bank In Hand	4 067	1 532	1 435	1 535		2 500	1 630
Debtors	6 031	3 234	2 568	2 705		2 498	2 000
Net Assets Liabilities Including Pension Asset Liability	7 485	3 203	2 136	2 581	5 566	3 598	3 380

Capital & Reserves
Called Up Share Capital	600	982	1 271	1 333	1 920	888	593
Profit Loss Account Reserve	6 885	2 221	865	1 248	3 646	2 710	2 787
Shareholder Funds	7 485	3 203	2 136	2 581	5 513	3 598	3 380

Other Financial Data
Average Number Employees During Period									2	2	2	2	2
Creditors							250		12 109	2 303	10 697	11 652	7 043
Net Current Assets Liabilities	7 485	3 203	2 136	2 581	5 513	3 598	3 380	1 630	43 453	99 760	102 368	24 679	61 725
Other Operating Expenses Format2											35 670	2 660	30 922
Profit Loss											82 838	9 012	49 916
Raw Materials Consumables Used											16 500	2 500	15 000
Staff Costs Employee Benefits Expense											21 547
Tax Tax Credit On Profit Or Loss On Ordinary Activities											19 431	2 114	11 709
Total Assets Less Current Liabilities	7 485	3 203	2 136	2 581	5 566	3 598	3 380	1 630	43 453	99 760	102 368	24 679	61 725
Turnover Revenue											175 986	16 286	107 547
Creditors Due Within One Year	2 613	1 563	1 867	1 659	1 903	1 400	250
Number Shares Allotted	600	982	1 271	1 333
Par Value Share	1	1	1	1
Prepayments Accrued Income Not Expressed Within Current Asset Subtotal				2 705	4 860	2 500
Profit Loss For Period					3 593	2 710
Share Capital Allotted Called Up Paid	600	982	1 271	1 333

Company staff

Adebanke A.

Role: Secretary

Appointed: 18 February 2005

Latest update: 11 November 2023

Yewande A.

Role: Director

Appointed: 17 February 2005

Latest update: 11 November 2023

People with significant control

Yewande A.

Notified on 1 January 2017

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

substantial control or influence

Accounts Documents

Account next due date	30 November 2024
Account last made up date	28 February 2023
Confirmation statement next due date	26 April 2024
Confirmation statement last made up date	12 April 2023

Annual Accounts 03 October 2012
Start Date For Period Covered By Report	2011-03-01
End Date For Period Covered By Report	2012-02-28
Date Approval Accounts	03 October 2012
Annual Accounts 20 September 2013
Start Date For Period Covered By Report	2012-02-29
End Date For Period Covered By Report	2013-02-28
Date Approval Accounts	20 September 2013
Annual Accounts 01 October 2014
Start Date For Period Covered By Report	2013-03-01
End Date For Period Covered By Report	2014-02-28
Date Approval Accounts	01 October 2014
Annual Accounts 29 October 2015
Start Date For Period Covered By Report	2014-03-01
End Date For Period Covered By Report	2015-02-28
Date Approval Accounts	29 October 2015
Annual Accounts 01 September 2016
Start Date For Period Covered By Report	2015-03-01
End Date For Period Covered By Report	2016-02-28
Date Approval Accounts	01 September 2016
Annual Accounts 2 October 2017
Start Date For Period Covered By Report	2016-02-29
End Date For Period Covered By Report	2017-02-28
Date Approval Accounts	2 October 2017
Annual Accounts
Start Date For Period Covered By Report	2017-03-01
End Date For Period Covered By Report	2018-02-28
Annual Accounts
Start Date For Period Covered By Report	2018-03-01
End Date For Period Covered By Report	2019-02-28
Annual Accounts
Start Date For Period Covered By Report	2019-03-01
End Date For Period Covered By Report	2020-02-28
Annual Accounts
Start Date For Period Covered By Report	2020-02-29
End Date For Period Covered By Report	2021-02-28
Annual Accounts
Start Date For Period Covered By Report	01 March 2021
End Date For Period Covered By Report	28 February 2022
Annual Accounts
Start Date For Period Covered By Report	01 March 2022
End Date For Period Covered By Report	28 February 2023

Adeypharma Ltd

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Adebanke A.

Yewande A.

People with significant control

Yewande A.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest Companies - by postcode